Cargando…
New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
Most patients with Diffuse Large B-cell Lymphoma (DLBCL) are old (>65 years of age) and this population is expected to increase in the following years. A simplified geriatric assessment based on a careful evaluation of the fitness status and comorbidities is essential to choose the correct intens...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351275/ https://www.ncbi.nlm.nih.gov/pubmed/37465115 http://dx.doi.org/10.3389/fonc.2023.1214026 |